Stocks and Investing Stocks and Investing
Tue, January 24, 2023

Matthew Harrison Maintained (BOLT) at Hold with Decreased Target to $3 on, Jan 24th, 2023


Published on 2024-10-28 01:03:50 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Bolt Biotherapeutics, Inc." (BOLT) at Hold with Decreased Target from $5 to $3 on, Jan 24th, 2023.

Matthew has made no other calls on BOLT in the last 4 months.



There is 1 other peer that has a rating on BOLT. Out of the 1 peers that are also analyzing BOLT, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Edward White of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $8 on, Tuesday, October 4th, 2022

Contributing Sources